Performance in Q4 2025 was driven by sequential margin expansion resulting from higher acuity, improved payer mix, and sustained cost controls. Management attributed growth in specific markets to targeted capital investments, such as ER expansions in Knoxville and a $10 million women's services investment in Birmingham. The company successfully reduced leverage from 7.4x to 6.6x year-over-year through a combination of operational improvements and the application of divestiture proceeds to debt reducti ...